SVA Insider Trading
Sinovac Biotech Ltd. (SVA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $464.9M, listed on NASDAQ, employing roughly 1,959 people, carrying a beta of 0.00 to the broader market. Sinovac Biotech Ltd. Led by Wei Dong Yin, public since 2003-09-26.
In the last 12 months, Sinovac Biotech Ltd. insiders made 0 buy transactions and 0 sale transactions.
| Date | Name | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 17, 2026 | Li Jiaqiang | 0 | $0.00 | $0 | |
| Mar 18, 2026 | LI JING (NMN) | 0 | $0.00 | $0 | |
| Mar 18, 2026 | Yang Guang (Helen) | 0 | $0.00 | $0 | |
| Mar 18, 2026 | GAO QIANG (NMN) | 0 | $0.00 | $0 | |
| Mar 18, 2026 | WANG NAN | 0 | $0.00 | $0 | |
| Mar 18, 2026 | WANG YU (NMN) | 0 | $0.00 | $0 | |
| Mar 18, 2026 | JIAO SHUGE | 0 | $0.00 | $0 | |
| Mar 18, 2026 | LO YUK LAM | 0 | $0.00 | $0 | |
| Mar 18, 2026 | QIU YU MIN | 0 | $0.00 | $0 | |
| Mar 18, 2026 | Yan Andrew Y | 0 | $0.00 | $0 |
How to Read SVA Insider Activity
Net insider activity is balanced over the trailing twelve months: 0 buys against 0 sales. Balanced activity typically reflects routine compensation-related vesting and tax-driven liquidity rather than directional information signals. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.
Learn how insider trading is reported and how to read the data →